Applied Genetic Technologies Corp/ US03820J1007 /
| 2022-11-30 9:55:34 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.39USD | - | 2,629 Turnover: 1,018.17 |
-Bid Size: - | -Ask Size: - | 0.39 | 0.38 |
GlobeNewswire
03-22
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
GlobeNewswire
02-08
Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to...
GlobeNewswire
01-08
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
GlobeNewswire
2023-08-28
APRINOIA Therapeutics Appoints Mark S. Shearman, Ph.D., as Chief Executive Officer
GlobeNewswire
2022-03-17
Adverum Appoints Rabia Gurses Ozden, M.D. and Soo J. Hong, M.B.A., to Board of Directors
GlobeNewswire
2022-02-14
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2021
GlobeNewswire
2022-02-08
AGTC Announces Robust Improvements in Visual Sensitivity in Adult and Pediatric Patients, and Plans ...
GlobeNewswire
2022-02-07
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 14, 2022
GlobeNewswire
2022-01-11
AGTC Exceeds Enrollment Target in SKYLINE Trial of AGTC-501 for the Treatment of X-linked Retinitis ...
GlobeNewswire
2021-12-06
AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
GlobeNewswire
2021-12-06
First Wave BioPharma’s CEO and President, James Sapirstein, to Participate in CEO Panel Discussion a...
GlobeNewswire
2021-11-12
AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at Upcoming American Academy of Ophthalm...
GlobeNewswire
2021-11-10
Otonomy Reports Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-11-09
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2021
GlobeNewswire
2021-11-02
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 9, 2021
